← Back to headlines
Novo Nordisk Halves Wegovy List Price in USA
Novo Nordisk is reducing the list price of its weight-loss drug Wegovy and diabetes drug Ozempic in the USA to improve patient access.
24 Feb, 13:07 — 24 Feb, 13:10
Moderate (27/100)
2 sourcesNarrow spread1 region
ℹAll sources from Denmark region
ℹOnly 2 sources cover this story
Perspective Analysis
Comparing sources…
How outlets covered this
Left-leaning
No articles
Coverage Timeline
First report: berlingske · 24 Feb, 13:07|Full coverage: All 2 sources within 2m|Window: 2m
Left-leaningCenterRight-leaning
Read at source (2 outlets)
politiken6d ago
Novo Nordisk halverer listeprisen på Wegovy i USA
Listepris på Wegovy og Ozempic får et nøk ned. Det skal give flere patienter adgang, siger USA-chef.
Read full article →berlingske6d ago
Novo Nordisk halverer listeprisen på Wegovy i USA
Listepris på Wegovy og Ozempic får et nøk ned. Det skal give flere patienter adgang, siger USA-chef.
Read full article →
